We will endeavour to bring you updates on practice news and interesting information from the world of gynaecology as they come to hand please click on any of the topics below for more information.

HyNOVA at Lifehouse


In the video, Dr Farrell discusses the HyNOVA trial at Chris O’Brien Lifehouse. The first HyNOVA participant was successfully randomised last week 👏 HyNOVA is a randomised study comparing hyperthermic/normothermic chemotherapy for stage III epithelial ovarian, fallopian tube &


Lynparza (Olaparib) for ovarian cancer maintenance treatment added tothe latest PBS list.


Australian women will now have affordable access to Lynparza (Olaparib) for ovarian cancer maintenance treatment after the drug was included in the latest PBS list. Treasurer Josh Frydenberg’s budget speech on Tuesday announced that from November 1 2020, Olaparib,


Podcast – Gynaecological Cancer Awareness Month


This week A/Prof Rhonda Farrell was interviewed for the Coogee Voice podcast hosted by Dr Marjorie O’Neill, the Member for Coogee in the NSW State Parliament. September is Gynaecological Cancer Awareness Month and is used as an opportunity to


“I knew I was in the right place”. A patient’s story.


“I knew I was in the right place”     “I was a very busy individual – a full-time, single working parent, with none of the risk factors. It’s a wicked cancer that doesn’t have any typical symptoms.” As


Most Read Paper in ANZJOG (2018-2019)


  “Is peritonectomy and hyperthermic intraperitoneal chemotherapy a new standard of treatment for advanced epithelial ovarian cancer?” Link to article: Click Here


$13.6 million for reproductive, childhood brain and other cancer clinical trials


Associate Professor Rhonda Farrell has been granted funding from the Morrison government for a clinical cancer trial. She is one of the 10 successful clinical trials that will be funded to find innovative cancer treatments for melanoma, reproductive and gynaecological


Page 1 of 41234